Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Ruriko Horio"'
Autor:
Khin Zay Yar Myint, Masamori Shimabuku, Ruriko Horio, Munehisa Kaneda, Yoko Shimizu, Junichi Taguchi
Publikováno v:
Cancer Treatment and Research Communications, Vol 35, Iss , Pp 100701- (2023)
Liquid biopsies can be a rapid, cost-effective and non-invasive alternative to tumour biopsies for detecting genetic mutations in somatic tumours. Genetic profiling of liquid biopsies can also be used to identify novel antigens for targeted therapy,
Externí odkaz:
https://doaj.org/article/196f2317e1394d06a86bc3d1358ae538
Autor:
Junichi Taguchi, Ruriko Horio
Publikováno v:
Health Evaluation and Promotion. 49:263-270
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab271e1f68167f489c97e6b6468e5ba4
https://doi.org/10.7143/jhep.49.263
https://doi.org/10.7143/jhep.49.263
Autor:
Masamori, Shimabuku, Junichi, Taguchi, Khin, Zay Yar Myint, Munehisa, Kaneda, Kenichi, Kashihara, Toshiomi, Kusano, Ruriko, Horio, Yoko, Shimizu, Katsuiku, Hirokawa
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 49(10)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0e48d6bbb21d2db7f6685fea92c82db5
https://pubmed.ncbi.nlm.nih.gov/36281598
https://pubmed.ncbi.nlm.nih.gov/36281598
Autor:
Khin Zay Yar Myint, Masamori Shimabuku, Kenichi Kashihara, Ruriko Horio, Munehisa Kaneda, Yoko Shimizu, Junichi Taguchi
Publikováno v:
Journal of Cancer Science and Clinical Therapeutics.
Tumor response and disease progression are assessed using imaging technologies. However, these technologies fail to detect tumor responses at the molecular level and clonal evolution. A potential surrogate for such parameters is using circulating tum
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7a070b5f2237910feded7134499b2934
https://doi.org/10.26502/jcsct.5079154
https://doi.org/10.26502/jcsct.5079154
Autor:
Masamori Shimabuku, Khin Zay Yar Myint, Junichi Taguchi, Yoko Shimizu, Munehisa Kaneda, Ruriko Horio
Liquid biopsies can be a rapid, cost-effective and noninvasive alternative to tumor biopsies for detecting genetic mutations in somatic tumors. Genetic profiling of liquid biopsies can also be used to identify novel antigens for targeted therapy, pro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4f4f265d748e8d8faf91cead9ba77473
https://doi.org/10.21203/rs.3.rs-1069498/v2
https://doi.org/10.21203/rs.3.rs-1069498/v2
